UNSPSC 51281501: Ethambutol

This classification denotes an antitubercular agent with the molecular formula C10H24N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8G167061QZ, chemically known as 2,2-(1,2-ethylenediimino)-di-1-butanol but generally known as ethambutol, which bears US NIH Compound Identifier 3279. European Medicines Agency schedules Ethambutol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07271MIG.

UNSPSC 51281501 Ethambutol is a Commodity code that does not align with the recent state and local procurement activity posted under this code. The source shows no recent solicitations for ethambutol, the tuberculosis medication that the code nominally describes. Instead, the opportunities tagged to this code cover naloxone procurement, direct-to-manufacturer pharmacy initiatives, medical and first aid supplies for emergency response, and generic multi-source pharmaceuticals and OTC products through cooperative purchasing. None of these solicitations involve ethambutol specifically, and the mismatch suggests either a cataloging error in how opportunities are being tagged to this code or that ethambutol procurement does not currently drive state and local demand under this classification.

The recent activity shown—Seminole County, Florida's IFB for naloxone and drug deactivation systems (posted June 30, 2026), the Texas Health and Human Services Commission's RFI for direct-to-manufacturer prescription programs (posted April 3, 2026), the City of Tampa's IFB for medical and first aid supplies for its Fire Department Rescue Division with an estimated contract value of $700,000 and sheltered-market SLBE set-aside (posted March 25, 2026), and the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products (posted January 20, 2026)—spans state health agencies, cities, counties, and cooperative purchasing vehicles across Florida, Texas, Minnesota, and Oregon. The code shows little to no relevant recent activity for vendors specializing in ethambutol or tuberculosis treatment pharmaceuticals at the state and local level. Firms pursuing this code should verify current cataloging practice or consider whether ethambutol demand exists through different procurement channels or UNSPSC classifications.